Epidemiology of Carbapenem-Resistant Enterobacteriaceae in Households of UTI Outpatients in Southwestern Uganda: An Urgent Need for One Health Approach
Background: Carbapenem-resistant Enterobacteriaceae (CRE) pose a major public health threat due to limited treatment options. Resistance driven by carbapenemase enzymes (such as blaVIM, blaKPC, blaIMP, blaNDM, and blaOXA-48), enables CRE to spread beyond healthcare settings into communities. The One Health approach is crucial for understanding the transmission pathways. This study investigated CRE distribution, resistance patterns, and genetic mechanisms among urinary tract infection (UTI) patients, their households, livestock, and environmental sources to inform strategies for controlling its spread. Methods: A cross-sectional study was conducted in two health centers in rural southwestern Uganda, involving 104 households (human, livestock and environment) of UTI outpatients who had Enterobacteriaceae harboring carbapenemase genes. The outpatients were traced to their homes. Urine samples were collected from a household member, stool samples from livestock, and boot sock samples from the environment. Enterobacteriaceae were identified, and the carbapenemase resistance genes (blaVIM, blaOXA-48, blaNDM, blaKPC, and blaIMP) identified using polymerase chain reaction. Data were analyzed using descriptive statistics and presented as frequencies and proportions in tables and charts. Results: Escherichia coli was the most abundant organism, while livestock demonstrated the most abundant growth of Enterobacteriaceae. Phenotypic carbapenem resistance was highest in the environment isolates (47.73%) whereas the genotypic carbapenemase resistance was highest in both human and environment isolates. Nearly a fifth of the households had at least one isolate carrying a carbapenemase gene, and 40% of the households had identical carbapenemase genes with UTI patients. Conclusions: The identification of matching carbapenemase genes between UTI patients and household isolates highlights the urgent need for targeted surveillance and infection control strategies to mitigate the spread of resistant pathogens. One Health epidemiological study designs are necessary for explaining the principal routes and dynamics of the spread of AMR bacteria between humans, livestock and the environment.
References
[1]
Bush, K. and Bradford, P.A. (2020) Epidemiology of β-Lactamase-Producing Pathogens. Clinical Microbiology Reviews, 33, e00047-19. https://doi.org/10.1128/CMR.00047-19
[2]
Nordmann, P., Naas, T. and Poirel, L. (2011) Global Spread of Carbapenemase-Producing Enterobacteriaceae. Emerging Infectious Diseases, 17, 1791-1798. https://doi.org/10.3201/eid1710.110655
[3]
Logan, L.K. and Weinstein, R.A. (2017) The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. The Journal of Infectious Diseases, 215, S28-S36. https://doi.org/10.1093/infdis/jiw282
[4]
Tiseo, K., Huber, L., Gilbert, M., Robinson, T.P. and Van Boeckel, T.P. (2020) Global Trends in Antimicrobial Use in Food Animals from 2017 to 2030. Antibiotics (Basel), 9, Article 918. https://doi.org/10.3390/antibiotics9120918
[5]
Ferdinand, A.S., Coppo, M.J.C., Howden, B.P. and Browning, G.F. (2023) Tackling Antimicrobial Resistance by Integrating One Health and the Sustainable Development Goals. BMC Global and Public Health, 1, Article No. 11. https://doi.org/10.1186/s44263-023-00003-8
[6]
Myers, J., Hennessey, M., Arnold, J.-C., McCubbin, K.D., Lembo, T., Mateus, A., Kitutu, F.E., Samanta, I., Hutchinson, E., Davis, A., Mmbaga, B.T., Nasuwa, F., Gautham, M. and Clarke, S.E. (2022) Crossover-Use of Human Antibiotics in Livestock in Agricultural Communities: A Qualitative Cross-Country Comparison between Uganda, Tanzania and India. Antibiotics, 11, Article 1342. https://doi.org/10.3390/antibiotics11101342
[7]
Cole, S.D., Perez-Bonilla, D., Hallowell, A. and Redding, L.E. (2022) Carbapenem Prescribing at a Veterinary Teaching Hospital before an Outbreak of Carbapenem-Resistant Escherichia coli. Journal of Small Animal Practice, 63, 442-446. https://doi.org/10.1111/jsap.13481
[8]
Smith, A., Wayne, A.S., Fellman, C.L. and Rosenbaum, M.H. (2019) Usage Patterns of Carbapenem Antimicrobials in Dogs and Cats at a Veterinary Tertiary Care Hospital. Journal of Veterinary Internal Medicine, 33, 1677-1685. https://doi.org/10.1111/jvim.15522
[9]
Tang, K.L., Caffrey, N.P., Nóbrega, D.B., Cork, S.C., Ronksley, P.E., Barkema, H.W., Polachek, A.J., Ganshorn, H., Sharma, N., Kellner, J.D. and Ghali, W.A. (2017) Restricting the Use of Antibiotics in Food-Producing Animals and Its Associations with Antibiotic Resistance in Food-Producing Animals and Human Beings: A Systematic Review and Meta-Analysis. The Lancet Planetary Health, 1, E316-E327. https://doi.org/10.1016/S2542-5196(17)30141-9
[10]
Kizny Gordon, A.E., Mathers, A.J., Cheong, E.Y.L., Gottlieb, T., Kotay, S., Walker, A.S., Peto, T.E.A., Crook, D.W. and Stoesser, N. (2017) The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections—A Systematic Review of the Literature. Clinical Infectious Diseases, 64, 1435-1444. https://doi.org/10.1093/cid/cix132
[11]
Tuhamize, B., Tusubira, D., Masembe, C., Bessong, P., Bazira, J. and Bessong, P.O. (2024) An Investigation into Carbapenem Resistance in Enterobacteriaceae among Outpatients with Urinary Tract Infection in Southwestern Uganda. Cureus, 16, e72387. https://doi.org/10.7759/cureus.72387
[12]
Zakrzewski, A.J., Zarzecka, U., Chajęcka-Wierzchowska, W. and Zadernowska, A. (2022) A Comparison of Methods for Identifying Enterobacterales Isolates from Fish and Prawns. Pathogens, 11, Article 410. https://doi.org/10.3390/pathogens11040410
[13]
Tuhamize, B., Asiimwe, B.B., Kasaza, K., Sabiiti, W., Holden, M. and Bazira, J. (2023) Klebsiella Pneumoniae Carbapenamases in Escherichia coli Isolated from Humans and Livestock in Rural South-Western Uganda. PLOS ONE, 18, e0288243. https://doi.org/10.1371/journal.pone.0288243
[14]
Poirel, L., Madec, J.Y., Lupo, A., Schink, A.K., Kieffer, N., Nordmann, P. and Schwarz, S. (2018) Antimicrobial Resistance in Escherichia coli. Microbiology Spectrum, 6. https://doi.org/10.1128/microbiolspec.ARBA-0026-2017
[15]
Wang, F., Zhang, W. and Niu, D. (2021) Editorial: Foodborne Enterobacteriaceae of Animal Origin. Frontiers in Cellular and Infection Microbiology, 11, Article 772359. https://doi.org/10.3389/fcimb.2021.772359
[16]
Madec, J.-Y., Haenni, M., Nordmann, P. and Poirel, L. (2017) Extended-Spectrum β-Lactamase/AmpC-and Carbapenemase-Producing Enterobacteriaceae in Animals: A Threat for Humans? Clinical Microbiology and Infection, 23, 826-833. https://doi.org/10.1016/j.cmi.2017.01.013
[17]
Mukuna, W., Aniume, T., Pokharel, B., Khwatenge, C., Basnet, A. and Kilonzo-Nthenge, A. (2023) Antimicrobial Susceptibility Profile of Pathogenic and Commensal Bacteria Recovered from Cattle and Goat Farms. Antibiotics (Basel), 12, Article 420. https://doi.org/10.3390/antibiotics12020420
[18]
Anene, C.C., Oli, A.N., Edeh, P.A., Okezie, M.U. and Kretchy, J.-P. (2021) Antimicrobial Resistance among Enterobacteriaceae Found in Chicken and Cow Droppings and Their Public Health Importance. Advances in Microbiology, 11, 694-711. https://doi.org/10.4236/aim.2021.1111050
[19]
Tuhamize, B. and Bazira, J. (2024) Carbapenem-Resistant Enterobacteriaceae in the Livestock, Humans and Environmental Samples around the Globe: A Systematic Review and Meta-Analysis. Scientific Reports, 14, Article No. 16333. https://doi.org/10.1038/s41598-024-64992-8
[20]
Feng, J., Xiang, Q., Ma, J., Zhang, P., Li, K., Wu, K., Su, M., Li, R., Hurley, D., Bai, L., Wang, J. and Yang, Z. (2021) Characterization of Carbapenem-Resistant Enterobacteriaceae Cultured from Retail Meat Products, Patients, and Porcine Excrement in China. Frontiers in Microbiology, 12, Article 743468. https://doi.org/10.3389/fmicb.2021.743468
[21]
Wyres, K.L. and Holt, K.E. (2018) Klebsiella Pneumoniae as a Key Trafficker of Drug Resistance Genes from Environmental to Clinically Important Bacteria. Current Opinion in Microbiology, 45, 131-139. https://doi.org/10.1016/j.mib.2018.04.004
[22]
Ssekatawa, K., Byarugaba, D.K., Nakavuma, J.L., Kato, C.D., Ejobi, F., Tweyongyere, R. and Wampande, E.M. (2020) Carbapenem Resistance Profiles of Pathogenic Escherichia coli in Uganda. European Journal of Biology and Biotechnology. Preprint (Version 1). https://doi.org/10.21203/rs.3.rs-125368/v1
[23]
Codjoe, F.S. and Donkor, E.S. (2018) Carbapenem Resistance: A Review. Medical Sciences, 6, Article 1. https://doi.org/10.3390/medsci6010001
[24]
Farra, A., Islam, S., Strålfors, A., Sörberg, M. and Wretlind, B. (2008) Role of Outer Membrane Protein OprD and Penicillin-Binding Proteins in Resistance of Pseudomonas aeruginosa to Imipenem and Meropenem. International Journal of Antimicrobial Agents, 31, 427-433. https://doi.org/10.1016/j.ijantimicag.2007.12.016
[25]
Lerner, A., Adler, A., Abu-Hanna, J., Meitus, I., Navon-Venezia, S. and Carmeli, Y. (2013) Environmental Contamination by Carbapenem-Resistant Enterobacteriaceae. Journal of Clinical Microbiology, 51, 177-181. https://doi.org/10.1128/JCM.01992-12
[26]
Nordmann, P. (2014) Carbapenemase-Producing Enterobacteriaceae: Overview of a Major Public Health Challenge. Médecine et Maladies Infectieuses, 44, 51-56. https://doi.org/10.1016/j.medmal.2013.11.007
[27]
Boyd, S.E., Holmes, A., Peck, R., Livermore, D.M. and Hope, W. (2022) OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline. Antimicrobial Agents and Chemotherapy, 66, e00216-00222. https://doi.org/10.1128/aac.00216-22
[28]
Meletis, G. (2016) Carbapenem Resistance: Overview of the Problem and Future Perspectives. Therapeutic Advances in Infectious Disease, 3, 15-21. https://doi.org/10.1177/2049936115621709
[29]
Meier, H., Spinner, K., Crump, L., Kuenzli, E., Schuepbach, G. and Zinsstag, J. (2023) State of Knowledge on the Acquisition, Diversity, Interspecies Attribution and Spread of Antimicrobial Resistance between Humans, Animals and the Environment: A Systematic Review. Antibiotics, 12, Article 73. https://doi.org/10.3390/antibiotics12010073
[30]
Ma, J., Song, X., Li, M., Yu, Z., Cheng, W., Yu, Z., Zhang, W., Zhang, Y., Shen, A., Sun, H. and Li, L. (2023) Global Spread of Carbapenem-Resistant Enterobacteriaceae: Epidemiological Features, Resistance Mechanisms, Detection and Therapy. Microbiological Research, 266, Article 127249. https://doi.org/10.1016/j.micres.2022.127249
[31]
Gatica, J., Jurkevitch, E. and Cytryn, E. (2019) Comparative Metagenomics and Network Analyses Provide Novel Insights into the Scope and Distribution of β-Lactamase Homologs in the Environment. Frontiers in Microbiology, 10, Article 146. https://doi.org/10.3389/fmicb.2019.00146
[32]
Atterby, C., Börjesson, S., Ny, S., Järhult, J.D., Byfors, S. and Bonnedahl, J. (2017) ESBL-Producing Escherichia coli in Swedish Gulls—A Case of Environmental Pollution from Humans? PLOS ONE, 12, e0190380. https://doi.org/10.1371/journal.pone.0190380
